227 related articles for article (PubMed ID: 22034498)
1. Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.
Zhang S; Kim K; Jin UH; Pfent C; Cao H; Amendt B; Liu X; Wilson-Robles H; Safe S
Mol Cancer Ther; 2012 Jan; 11(1):108-18. PubMed ID: 22034498
[TBL] [Abstract][Full Text] [Related]
2. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
Hanieh H
Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
[TBL] [Abstract][Full Text] [Related]
3. The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy.
Zhang S; Lei P; Liu X; Li X; Walker K; Kotha L; Rowlands C; Safe S
Endocr Relat Cancer; 2009 Sep; 16(3):835-44. PubMed ID: 19447902
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the aryl hydrocarbon receptor ligand 6-methyl-1,3,8-trichlorodibenzofuran with estrogen receptor alpha.
Pearce ST; Liu H; Radhakrishnan I; Abdelrahim M; Safe S; Jordan VC
Cancer Res; 2004 Apr; 64(8):2889-97. PubMed ID: 15087408
[TBL] [Abstract][Full Text] [Related]
5. Lack of antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDDs) induction of cytochrome P4501A1 (CYP1A1) by the putative selective aryl hydrocarbon receptor modulator 6-alkyl-1,3,8-trichlorodibenzofuran (6-MCDF) in the mouse hepatoma cell line Hepa-1c1c7.
Fretland AJ; Safe S; Hankinson O
Chem Biol Interact; 2004 Nov; 150(2):161-70. PubMed ID: 15535986
[TBL] [Abstract][Full Text] [Related]
6. The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis.
Jin UH; Lee SO; Pfent C; Safe S
BMC Cancer; 2014 Jul; 14():498. PubMed ID: 25011475
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor-mediated inhibition of LNCaP prostate cancer cell growth and hormone-induced transactivation.
Morrow D; Qin C; Smith R; Safe S
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):27-36. PubMed ID: 15026081
[TBL] [Abstract][Full Text] [Related]
8. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells.
Wormke M; Castro-Rivera E; Chen I; Safe S
J Steroid Biochem Mol Biol; 2000 Apr; 72(5):197-207. PubMed ID: 10822009
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor (AHR) regulation of L-Type Amino Acid Transporter 1 (LAT-1) expression in MCF-7 and MDA-MB-231 breast cancer cells.
Tomblin JK; Arthur S; Primerano DA; Chaudhry AR; Fan J; Denvir J; Salisbury TB
Biochem Pharmacol; 2016 Apr; 106():94-103. PubMed ID: 26944194
[TBL] [Abstract][Full Text] [Related]
10. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
Angus WG; Larsen MC; Jefcoate CR
Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
[TBL] [Abstract][Full Text] [Related]
12. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.
Klinge CM; Bowers JL; Kulakosky PC; Kamboj KK; Swanson HI
Mol Cell Endocrinol; 1999 Nov; 157(1-2):105-19. PubMed ID: 10619402
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of inhibition of MDA-MB-468 breast cancer cell growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Wang WL; Porter W; Burghardt R; Safe SH
Carcinogenesis; 1997 May; 18(5):925-33. PubMed ID: 9163677
[TBL] [Abstract][Full Text] [Related]
14. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.
Döhr O; Vogel C; Abel J
Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor (AHR)-active pharmaceuticals are selective AHR modulators in MDA-MB-468 and BT474 breast cancer cells.
Jin UH; Lee SO; Safe S
J Pharmacol Exp Ther; 2012 Nov; 343(2):333-41. PubMed ID: 22879383
[TBL] [Abstract][Full Text] [Related]
16. The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells.
Bekki K; Vogel H; Li W; Ito T; Sweeney C; Haarmann-Stemmann T; Matsumura F; Vogel CF
Pestic Biochem Physiol; 2015 May; 120():5-13. PubMed ID: 25987214
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cells.
Liu S; Abdelrahim M; Khan S; Ariazi E; Jordan VC; Safe S
Biol Chem; 2006 Sep; 387(9):1209-13. PubMed ID: 16972788
[TBL] [Abstract][Full Text] [Related]
18. Comparative antiestrogenic activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 6-methyl-1,3,8-trichlorodibenzofuran in the female rat.
Astroff B; Safe S
Toxicol Appl Pharmacol; 1988 Sep; 95(3):435-43. PubMed ID: 2847362
[TBL] [Abstract][Full Text] [Related]
19. Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies.
Harris M; Zacharewski T; Astroff B; Safe S
Mol Pharmacol; 1989 May; 35(5):729-35. PubMed ID: 2542761
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor-independent activation of estrogen receptor-dependent transcription by 3-methylcholanthrene.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2006 Jun; 213(2):87-97. PubMed ID: 16257430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
